Nucana Plc Form 6-K Summary
Business Context and Reporting Period
This Form 6-K was filed by Nucana Plc, a foreign private issuer headquartered in Edinburgh, United Kingdom, on June 20, 2025. The report discloses an "Other Event" regarding the listing status of the Company's American Depositary Shares (ADSs) on The Nasdaq Capital Market under the symbol "NCNA".
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on regulatory compliance regarding stock listing requirements rather than financial performance.
Material Changes
On June 18, 2025, the Company received a written notification from Nasdaq stating that the closing bid price of its ADSs had been below the $1.00 per share minimum bid price requirement for 30 consecutive trading days. This deficiency violates Nasdaq Listing Rule 5550(a)(2). There is no immediate effect on the listing, and the ADSs continue to trade.
Outlook, Risks, and Management Commentary
- Compliance Timeline: The Company has until December 15, 2025, to regain compliance with the bid price requirement.
- Compliance Criteria: To cure the deficiency, the closing bid price must be at least $1.00 per share for a minimum of 10 consecutive business days prior to the compliance date.
- Delisting Risk: If the Company fails to cure the deficiency within the 180-day period (or any granted extension), Nasdaq will issue a delisting notice.
- Appeal Process: The Company would be entitled to appeal a delisting determination to a Nasdaq Listing Qualifications Panel, though there is no assurance of success.
- Management Action: Management intends to actively monitor the closing bid price and may consider implementing available options to regain compliance.
Key Facts for Investor Verification
- Verify the current closing bid price of Nucana Plc ADSs (NCNA) to assess proximity to the $1.00 threshold.
- Monitor the Company's stock price performance over the next 10 consecutive business days to determine if compliance can be achieved before the December 15, 2025, deadline.
- Review future filings for any announcements regarding reverse stock splits or other corporate actions intended to address the bid price deficiency.
- Confirm whether the Company has filed any additional reports detailing specific strategies to regain compliance.